PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research, Singapore City, Singapore.\', \'Singapore Immunology Network, Agency for Science, Technology and Research, Singapore City, Singapore.\', \'Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.\', \'Department of Infectious Diseases, Changi General Hospital, Singapore City, Singapore.\', \'Department of Infectious Diseases, Singapore General Hospital, Singapore City, Singapore.\', \'Emerging Infectious Diseases Program, Duke-NUS Medical School, Singapore City, Singapore.\', \'National Centre for Infectious Diseases, Singapore City, Singapore.\', \'Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore City, Singapore.\', \'Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore City, Singapore.\', \'Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.\', \'Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.\', \'Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, Liverpool, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/emmm.202114045
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 33961735
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all